Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith R McCrae

Showing results (131-140 of 153) with videos related to

Pageof 16
Sort By:
Vascular Medicine (London, England)|May 19, 2021
Effect of aspirin on short-term outcomes in hospitalized patients with COVID-19Aditya Sahai, Rohan Bhandari, Matthew Godwin, et al.
Med (New York, N.Y.)|May 26, 2021
Increased Incidence of Venous Thromboembolism with Cancer ImmunotherapyJoanna Roopkumar, Shadi Swaidani, Ann S Kim, et al.
Blood Advances|December 4, 2019
American Society of Hematology 2019 guidelines for immune thrombocytopeniaCindy Neunert, Deirdra R Terrell, Donald M Arnold, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 8, 2023
Factor XII promotes the thromboinflammatory response in a rat model of venoarterial extracorporeal membrane oxygenationMousa Kharnaf, Farhan Zafar, Spencer Hogue, et al.
Journal of Thrombosis and Haemostasis : JTH|October 15, 2025
Validation and clinical application of the hereditary hemorrhagic telangiectasia-specific quality of life scaleHanny Al-Samkari, Raj S Kasthuri, Vivek N Iyer, et al.
Research Square|January 5, 2021
SARS-CoV-2 Receptors are Expressed on Human Platelets and the Effect of Aspirin on Clinical Outcomes in COVID-19 PatientsAditya Sahai, Rohan Bhandari, Milka Koupenova, et al.
Expert Review of Hematology|June 8, 2026
A call to action for the use of composite hematologic measurements in hereditary hemorrhagic telangiectasia and other chronic bleeding disordersHanny Al-Samkari, Raj S Kasthuri, Jenny Y Zhou, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 26, 2018
Factor XII Activation Promotes Platelet Consumption in the Presence of Bacterial-Type Long-Chain Polyphosphate In Vitro and In VivoJevgenia Zilberman-Rudenko, Stéphanie E Reitsma, Cristina Puy, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Antiphospholipid syndrome (APS) is a platelet factor 4 (PF4)-centric immunothrombotic disorderConroy O Field, Amrita Sarkar, Khalil Bdeir, et al.
Blood|June 30, 2026
Antiphospholipid syndrome (APS) is a platelet factor 4 (PF4)-centric immunothrombotic disorderConroy O Field, Amrita Sarkar, Khalil Bdeir, et al.
Pageof 16

Showing results (131-140 of 153) with videos related to

Sort By:
Pageof 16
Vascular Medicine (London, England)|May 19, 2021
Effect of aspirin on short-term outcomes in hospitalized patients with COVID-19Aditya Sahai, Rohan Bhandari, Matthew Godwin, et al.
Med (New York, N.Y.)|May 26, 2021
Increased Incidence of Venous Thromboembolism with Cancer ImmunotherapyJoanna Roopkumar, Shadi Swaidani, Ann S Kim, et al.
Blood Advances|December 4, 2019
American Society of Hematology 2019 guidelines for immune thrombocytopeniaCindy Neunert, Deirdra R Terrell, Donald M Arnold, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 8, 2023
Factor XII promotes the thromboinflammatory response in a rat model of venoarterial extracorporeal membrane oxygenationMousa Kharnaf, Farhan Zafar, Spencer Hogue, et al.
Journal of Thrombosis and Haemostasis : JTH|October 15, 2025
Validation and clinical application of the hereditary hemorrhagic telangiectasia-specific quality of life scaleHanny Al-Samkari, Raj S Kasthuri, Vivek N Iyer, et al.
Research Square|January 5, 2021
SARS-CoV-2 Receptors are Expressed on Human Platelets and the Effect of Aspirin on Clinical Outcomes in COVID-19 PatientsAditya Sahai, Rohan Bhandari, Milka Koupenova, et al.
Expert Review of Hematology|June 8, 2026
A call to action for the use of composite hematologic measurements in hereditary hemorrhagic telangiectasia and other chronic bleeding disordersHanny Al-Samkari, Raj S Kasthuri, Jenny Y Zhou, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 26, 2018
Factor XII Activation Promotes Platelet Consumption in the Presence of Bacterial-Type Long-Chain Polyphosphate In Vitro and In VivoJevgenia Zilberman-Rudenko, Stéphanie E Reitsma, Cristina Puy, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Antiphospholipid syndrome (APS) is a platelet factor 4 (PF4)-centric immunothrombotic disorderConroy O Field, Amrita Sarkar, Khalil Bdeir, et al.
Blood|June 30, 2026
Antiphospholipid syndrome (APS) is a platelet factor 4 (PF4)-centric immunothrombotic disorderConroy O Field, Amrita Sarkar, Khalil Bdeir, et al.
Pageof 16